1-204141428-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_018208.4(ETNK2):āc.671T>Cā(p.Val224Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000554 in 1,606,070 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_018208.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ETNK2 | NM_018208.4 | c.671T>C | p.Val224Ala | missense_variant | 4/8 | ENST00000367202.9 | |
ERLNC1 | NR_123739.1 | n.21A>G | non_coding_transcript_exon_variant | 1/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ETNK2 | ENST00000367202.9 | c.671T>C | p.Val224Ala | missense_variant | 4/8 | 1 | NM_018208.4 | P1 | |
ERLNC1 | ENST00000658822.1 | n.25A>G | non_coding_transcript_exon_variant | 1/2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152190Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000298 AC: 7AN: 235168Hom.: 0 AF XY: 0.0000316 AC XY: 4AN XY: 126778
GnomAD4 exome AF: 0.0000605 AC: 88AN: 1453880Hom.: 0 Cov.: 31 AF XY: 0.0000609 AC XY: 44AN XY: 722432
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152190Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74348
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 31, 2023 | The c.671T>C (p.V224A) alteration is located in exon 4 (coding exon 4) of the ETNK2 gene. This alteration results from a T to C substitution at nucleotide position 671, causing the valine (V) at amino acid position 224 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at